Market Tracker

10/23 5:15pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
4.38 +0.06 / +1.39%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.38 -0.0004 / -0.01%
 
Volume: 3.8K

Today’s Trading

Previous close4.32
Today’s open4.39
Day’s range4.24 - 4.49
Volume2,902,955
Average volume (3 months)4,194,733
Market cap$529.4M
Dividend yield--
Data as of 3:59pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+92.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book10.83

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.41+2.13%
PRTAProthena Corporation...+1.58+8.32%
FLMLFlamel Technologies ...+0.29+2.29%
SPPISpectrum Pharmaceuti...+0.38+5.11%
Data as of 3:59pm ET, 10/23/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts